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The cochlea is a complex system of cells that converts mechanical energy into 
electrical activity that can be sent to the brain for perception of sound (Ohlemiller & 
Clark, 2008). The cochlea is surrounded by a bony covering, inside of which there are 
three fluid filled spaces. The cochlear spaces are divided by Reissner’s membrane (upper 
divider) and the reticular lamina (lower divider). The middle space, or scala media, 
contains a special fluid called endolymph that is potassium rich and positively charged. 
On the lateral wall inside the scala media is a thick and vascular structure called the stria 
vascularis (SV). This group of specialized cells maintains the high potassium 
concentration of endolymph by pumping potassium ions into the scala media. Also inside 
of the scala media, resting upon the basilar membrane is the organ of Corti. Which is 
comprised of sensory cells and supporting cells. These sensory cells consist of the inner 
hair cells (IHCs) and outer hair cells (OHCs). The organ of Corti sits upon the basilar 
membrane, allowing it to move in reaction to mechanical stimulation from the 
transmission of sound to the cochlea. Inner and outer hair cells contain stereocilia, or 
“hair like” projections at their apex. These stereocilia are connected to each other by a 
series of tip links that act as springs. Deflection of stereocilia leads to opening of 
transduction channels, allowing potassium to flow from the endolymph into the cell 
thereby causing a depolarization. As the IHCs are stimulated, they release 
neurotransmitter, which activates auditory neurons and leads to perception of sound by 
the brain. The potassium that entered into the hair cells is commonly believed to be 
recycled back to the scala media by way of the lateral wall and stria vascularis, making 




Requirements of normal cochlear function 
 The cochlea is remarkable in that sound frequency is mapped (tonotopic) along 
its length. Specifically, the higher frequencies are perceived at the lower (basal) end of 
the cochlea and lower frequency sounds are perceived at the upper (apical) end. This 
tonotopic organization is achieved by several mechanisms. The first mechanism is 
defined by the physical properties of the cochlea.  As described by the simple harmonic 
motion equation: ω= √(κ/m). Where the resonant frequency (ω) is equal to the square 
root of stiffness (κ) divided by mass (m). This equation describes the resonant frequency 
of any physical object or system, but the cochlea uses this physical law to its advantage. 
Each point along the length of the cochlea has a natural resonant frequency that it 
responds best to. At the basal end of the cochlea, the mechanical system is primarily 
driven by its stiffness making its resonant frequency higher. At the apical end, of the 
cochlea the mechanical system is primarily driven by its mass, making its resonant 
frequency lower. The physical properties are not the only way the cochlea is highly 
frequency responsive. A second mechanism involving the IHCs and auditory nerve have 
been found to show a preference for specific frequencies to which they will optimally 
respond. Most amazingly, the cochlea is not a passive system. Outer hair cells actively 
change the stiffness of the cochlea to increase frequency sensitivity and resolution. This 
tuning is achieved by the motility of molecules called prestin, which are located in the 
cell walls of OHCs. Neural stimulation causes these prestin motor molecules to contract 
or elongate, changing the length of OHCs and physical properties of the basilar 
membrane, thus changing the frequency resolution (Clark & Ohlemiller, 2008). The 
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actions and function of the cochlea and its components are only briefly described here, 
although this should provide the audience with a foundation of cochlear mechanisms. 
 
Importance of animal models for the study of cochlear injury 
 If the IHCs, OHCs, afferent neurons or SV are damaged, the cochlea can no 
longer efficiently transmit signals to the brain. These cells can be damaged by excessive 
noise, ototoxic drugs, infections in the inner ear, and aging. Once damaged, these cells 
cannot regenerate in mammals. The study of repair within the mammalian cochlea 
following insult is vital for future research into hair cell regeneration. 
Animal models are used in biomedical research, and the most common model 
organism is the mouse. Its many advantages including its fast reproduction rate, relatively 
short life span, sequenced genome and naturally occurring mutations that are 
phenotypically similar to humans have led the mouse to be called “biomedicine’s model 
mammal” (Malakoff, 2000). In addition, inbred stains of mice show less inter-animal 
variability in studies of noise induced hearing losses than do other animal models (Wang, 
Hirose, & Liberman, 2002). This homogeneity of functional and structural changes is 
desirable for identification of cellular events and primary targets of cochlear insults.  
Indeed, the mouse has been widely used to study heredity of hearing disorders, noise 
induced hearing loss, and ototoxicity (Henely and Rybak, 1995; Prosser, Rzadzinska, 
Steel, & Bradley, 2008; Wang et al., 2002; Wu, Sha, McLaren, Kawamoto, Raphael, & 





Animal models in ototoxic injury 
Despite the many attributes of mice as a research tool, adult mice have proven 
very resistant to ototoxic insult (Henry, Chole, McGinn, & Erush, 1981; Chen and 
Saunders, 1983).  Henry and other researchers described a “sensitive period” in young 
mice ten to twenty days after birth as the only time that mouse cochleae are susceptible to 
either ototoxic aminoglycosides or aminoglycosides combined with loop diuretics.  These 
findings made the mouse undesirable for use in ototoxicity studies, due to the 
complicating factor of cochlear development. With these findings, few aminoglycoside 
studies utilized mice until Wu and colleagues (2001) discovered that a regimen of twice 
daily doses of aminoglycosides for fifteen days would result in elevated auditory 
brainstem response (ABR) thresholds and cochlear lesions in adult mice. Though 
effective, this protocol is time intensive and therefore limits the number of animals that 
can be studied within a given period of time.   
 Recently however, two protocols have demonstrated that single doses of both a 
loop diuretic and an aminoglycoside will cause a significant cochlear lesion in adult mice 
(Oesterle, Campbell, Taylor, Forge, & Hume, 2008; Taylor, Nevill, & Forge, 2008). Both 
studies described cochlear lesions that extend from base to apex, and affect primarily 
OHCs, the SV, and some IHCs. A similar synergistic reaction of aminoglycosides and 
loop diuretics has previously been documented in other animal models and in humans 
(Abrashkin, Izumikawa, Miyazawa, Wang, Crumling, & Swiderski, 2006; Guthrie, 
2008). Aminoglycosides and loop diuretics have also been shown to be ototoxic 
independently in many other mammals (Guthrie, 2008; Rybak, 1984).  
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Ototoxic drugs of the aminoglycoside family first brought attention to ototoxic 
medications when they were widely used in the 1940s and 1950s to treat tuberculosis. 
Animal studies revealed the aminoglycosides to specifically damage the hair cells, 
causing hearing loss. Due to their side effects, aminoglycosides fell out of favor in all but 
developing countries, where their effectiveness in treating infection and their low cost 
continues to make them an attractive form of treatment (Forge & Schacht, 2000). At 
times the use of some ototoxic drugs is unavoidable. Although hearing is monitored on 
these occasions, in hopes of being able to reduce the drug dosage once hearing loss 
begins, hearing loss still occurs.  
Animal studies have found that aminoglycosides damage OHCs and some 
marginal cells in the stria vascularis (Forge & Schacht, 2000). This damage occurs 
progressively along the length of the cochlea. The high- frequency (basal) region of the 
cochlea being affected first and progressing apically to lower frequencies. 
Aminoglycosides appear to readily cause greater OHC damage than to other cells within 
the cochlea. The reason for specific OHC damage remains unclear, but it is thought to 
relate to transduction channels within the OHC.  
In contrast, loop diuretics typically cause a temporary hearing loss that reverses 
several hours after cessation of treatment. Animal studies have indicated a reversible 
decrease in blood flow to the lateral wall of the entire cochlea and reduced endocochlear 
potential in the scala media (Ding, McFadden, Woo, & Salvi 2002; Rybak 1993).  
When combined together, loop diuretics and aminoglycosides work 
synergistically in their effects on the cochlea. Loop diuretics are known to significantly 
enhance uptake of aminoglycosides into the endolymph of the scala media (Tran Ba Huy, 
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Muelemans, Manuel, Sterkers, & Wassef, 1981). If a major route of aminoglycoside 
entry into the OHCs is through the transduction channels of the stereocilia (Marcotti, van 
Netten, & Kros, 2005), then the higher concentrations of aminoglycosides would increase 
the access of aminoglycosides into OHCs. In guinea pig studies OHC loss is greatly dose 
dependent on both kanamycin and furosemide dosing. When hair cell loss is plotted as a 
function of aminoglycoside dosage and loop diuretic dosage is held constant the slope of 
OHC loss to aminoglycoside dosage is less than when aminoglycoside is held constant 
and loop diuretic is varied (Brummett, Brown, & Himes, 1979). Brummett and colleagues 
theorized that this difference in slope when comparing the two dosing strategies indicated 
different mechanisms of ototoxic damage exerted by the different drugs.  
Mononuclear phagocytes in the inner ear 
White blood cells such as mononuclear phagocytes migrate throughout the body 
and may differentiate to tissue-specific resident macrophages or they may remain in the 
vasculature system and migrate to parts of the body that express proinflammatory signals 
(Hirose, Discolo, Keasler, & Ransohoff, 2005). After cochlear damage, mononuclear 
phagocytes are recruited into the cochlea to join resident macrophages and remove 
cellular debris (Fredelius and Rask-Andersen, 1990; Hirose et al, 2005; Okano, 
Nakagawa, Kita, Kada, Yoshimoto, Nakahata, & Ito, 2008; Sato, Shick, Ransohoff , & 
Hirose, 2008). These inflammatory cells and “professional cleaners” have been studied in 
both noise and drug induced lesions, although their ability to phagocytose apoptotic cells 
within the cochlea is not completely understood (Tan, Lee, & Ruan, 2008). Sato and 
colleagues (2008) found that the role of the CX3CR1 fractalkine receptor on 
macrophages could affect the degree of cochlear damage, depending on the method of 
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cochlear lesion. The ability to modulate the extent of epithelial injury makes their study 
critical to understanding mechanisms of cochlear repair.  
 To reveal damage to the sensory epithelium caused by ototoxic exposure and 
subsequent mononuclear phagocyte migration into the cochlea, immunohistochemistry 
has been applied to track two proteins of particular interest. The first is Myosin VIIa, a 
myosin transport molecule critical to HC stereocilia length and tip link regulation. 
Mutations of the Myosin VIIa gene have been linked inner ear dysfunction in shaker1 in 
mice and Usher 1B syndrome in humans (Hasson, 1999; Manor & Kachar, 2008; Prosser, 
Rzadzinska, Steel, & Bradley, 2008). In normally developed mice immunoreactivity for 
Myosin VIIa can be used to label IHC and OHC. The second is CD45, a receptor 
common to leukocytes, including macrophages (Tan, et al., 2008). This receptor is 
present on all leukocytes created within bone marrow and not expressed by cells of 
cochlear origin. Therefore the labeling of CD45 allows for quantification of leukocyte 
migration within the cochlea (Hirose et al., 2005; Sato et al., 2008; Tan et al., 2008). The 
majority of these cochlear leukocytes have been shown to be macrophages in prior work 
(Hirose et al., 2005).   
 The current study will test the following predictions: (i) kanamycin and 
furosemide intraperitoneal (IP) injection will create a rapid hair cell lesion in the cochlea 
when compared to mice receiving saline IP injections, (ii) ototoxic lesioning within the 
cochlea will result in recruitment of mononuclear phagocytes shortly after damage. Also, 
these phagocytes will remain for sometime after injury to “clean up” injured cells, and 




MATERIALS AND METHODS 
Animals 
 We analyzed forty left cochleae from four-week-old male CBA/CaJ mice. The 
mice were obtained from a previous study that used an identical kanamycin and 
furosemide injection protocol. The CBA/CaJ mouse strain was selected due to its known 
stability in hearing thresholds during aging, its resistance to otitis media and its extensive 
use as a normal hearing control mouse (Zheng, Johnson, & Erway, 1999). Ten additional 
five-week-old male CBA/CaJ mice were added, utilizing both the right and left cochleae.  
All mice were purchased from Jackson Laboratory and were housed in the Washington 
University School of Medicine mouse colony for the duration of the study. Mice were 
randomly divided into five groups; control, two, five, fourteen and twenty-eight days 
survival after injection. Data from two mice in the study from the postinjection day two 
group were not included in the study. The first mouse had an adverse reaction to the 
injection and the second lost a significant amount of furosemide from the injection site. 
All procedures were approved by the Animal Studies Committee at Washington 




Group N Right Cochleae Left Cochleae 
Post Injection Day 2 10 4 10 
Post Injection Day 5 12 4 12 
Post Injection Day 14 8  8 
Post Injection Day 28 8   8 
Control  10 2 10 






 Mice received 1000mg/kg of kanamycin (Sigma Aldrich, St Louis, MO) dissolved 
in 0.9% NaCl saline solution (Hospira, Lake Forest, IL) followed forty-five minutes later 
by 400mg/kg of furosemide (Wockhardt Limited, Bedminster, NJ). Injections were 
delivered intraperitoneally. No mice expired from treatment. All mice experienced a 
subcutaneous bolus at injection sites at the time of injection, which later resolved.  
Control mice were injected with 0.9% NaCl saline solution of volumes equal to those 
given to kanamycin and furosemide injected mice.  
Cochlea preparation 
 Mice were euthanized with sodium pentabarbitol and endocardially perfused with 
4.0% Paraformaldehyde and 0.008% CaCl2 in a 0.065 M phosphate buffer. The bulla was 
then opened and cochleae were removed. Oval and round windows were opened, to allow 
for intralabyrinthine perfusion of fixative overnight at 4°C.  The cochleae were 
decalcified in 0.1 M ethylenediamineteraacetic acid (EDTA) for seven days at 4°C.  Left 
cochleae were then placed in cryoprotection solution for seven days and later frozen in a 
30% sucrose solution on dry ice. Cochleae were sectioned on a horizontal sliding 
microtome in 30μm sections, moving from round window to oval window in the mid-
modiolar plane. Sections were then stored in 48-well culture plate in cryostorage solution 
at -20°C. Ten right cochleae were dissected for whole mount immunohistochemical 
labeling, after having been immersed in cryoprotection solution for at least seven days.   
Immunohistochemistry 
 Mid-modiolar sections were first rinsed in 0.1M phosphate buffered solution for 
thirty minutes. Non-specific antibody binding was blocked by incubation in 10% normal 
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goat serum in phosphate 
buffered 0.1% Triton X-
100 for a minimum of two 
hours. Sections were then 
incubated overnight in 
primary antibodies, which 
consisted of CD45, 
(1:6000, Serotec), Myosin 
VIIa, (1:500, Proteus 
Bioscience) or both. The 
next day, specimens were immersed in secondary antibodies of either Alexa488-
conjugated anti-rat or anti-rabbit IgG (1:5000, Molecular Probes, 1:500, Molecular 
Probes), or Cy3 anti-rabbit IgG (1:500, GE Health). Some specimens were 
immunostained with only one antibody and were then counterstained with Alexa594-
conjugated phalloidin (1: 1000, Molecular Probes). All sections and whole mount tis
were counter-stained with 4’, 6-diamidino, 2-phenylindole dihydrochloride (DAPI) 
(1:500, Molecular Probes) to label cell nuclei. Labeled cochlear sections were mounted 
on microscope slides using Vectashield, coverslipped, and either imaged with an upright 
epifluorescence microscope or used for macrophage counts.  Imag
Fig. 1. Areas of the cochlea that were included in CD45+ cell 
counts. 
sues 
es were optimized for 






Fig. 2. Progression of outer hair cell damage apically (A,C, & E) and basally (B, D,  F, & G). A) Image of a 
control mouse whole mount preparation labeled for Myosin VIIa (red) with DAPI (blue). All outer hair cells are 
present. B) Basal area of control mouse. All OHCs are present with nuclei clearly marked. C) Two days after 
injections of kanamycin and furosemide OHC are intact apically. D) Two days after injections in the basal area. 
Some OHCs the apical surface of the reticular lamina appears intact with Myosin VIIa still clearly labeled, but 
nuclei are absent (arrows). E) Five days after injections OHC are absent even apically. F) Five days after 
injections OHCs are absent basally. G) Two days after injection. Image of same portion of the basal turn shown 
in D with DAPI showing disorganized nuclei. 
 
CD45 counts 
 CD45+ cells were counted from four cochleae per survival time. From each 
cochlea four sections were used to calculate an average per section. Specimens were 
viewed on an Olympus BX51 microscope under a 40X objective, with standard 
epifluorescence. Each section was divided into four areas: Area 2 (lower basal), Area 3 
14 
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(upper basal), Area 4 (lower apical) and Area 5 (upper apical), as shown in Figure 1. 
These areas were defined as having an approximate center frequency of 45, 20, 8, and 4 
kHz, respectively. All CD45+ cells were counted by focusing through the entire 30μm 
section. All cell counts from each area and postinjection day were averaged, in order to 
calculate typical CD45+ cells within the cochlea after ototoxic insult.   
RESULTS  
Hair cell loss progression 
 Whole mounts of 
cochleae were fixed at 
control, two, and five 
days postinjection and 
immunolabeled for 
MyosinVIIa in order to 
identify IHCs and OHCs 
within the organ of 
Corti. In control whole 
mounts both DAPI and 
Myosin VIIa were 
clearly labeled marking OHCs and IHCs present in both the base and apex of the cochlea. 
Two days postinjection, the OHCs showed marked signs of damage in the basal area of 
the cochlea where nuclei were absent while IHCs showed no loss of nuclei (Figure 2). 
OHC damage basally at PID two was observed mainly in the DAPI channel where some 
OHC nuclei were absent. By five days postinjection, the OHCs were absent both basally 
Fig. 3. By five days postinjection almost all OHC are absent except 
for a few at the extreme apex. 
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and apically in the cochlea. At PID five, only very few OHCs were present at the extreme 
apex (Figure 3).  
CD45+ cell recruitment following lesion 
We observed CD45+ cells actively recruited to the murine cochlea after ototoxic 
injury two days after injection of kanamycin and furosemide. Increased numbers of these 
cells were within the spiral 
ligament, spiral limbus, spiral 
ganglion, and modiolus. 
Macrophages were notably absent 
within the organ of Corti at all 
time points. Labeled CD45+ cells 
were counted in each frequency-
centered area of the cochlea, as 
shown in Figure 1. Analysis of 
Variance (ANOVA) was used to 
determine if any of the 
macrophage counts on a given 
postinjection day differed significantly from each other. We found that there was 
significant variance between at least one of the PIDs when compared to the control 
(p=0.007). Dunnett’s t-test was used to determine which time points differed significantly 
from controls. In our mice subjects, an overall increase of CD45+ cells was statistically 
significant at five and fourteen days after injection of kanamycin and furosemide. CD45+ 
cells were elevated at PID two and were most prominent at PID five. At PID fourteen and 
Fig. 4. Average of CD 45+ cells in each cochlea 
section by post injection days.  
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twenty-eight CD45+ cells decreased in number, although they still remained elevated 
from mice untreated with kanamycin and furosemide (Figures 4 and 5). This trend was 
observed in all areas of the cochlea (Figure 6).  
Fig. 5. Progression of CD45+ cells (green) recruitment within the upper basal area of the cochlea. Phalloidin (red) 
was used to counter stain cochlear structures. A) In control mice resident macrophages can be visualized in the 
spiral ligament (SLG) and absent in the spiral limbus (SL), spiral ganglion (SG), and scala vestibuli (SVI). B) Two 
days after injection of kanamycin and furosemide CD45+cells can begin to be seen migrating into the cochlea, 
especially in the SLG, SL and SV. C) By five days after injection a statistically significant amount of CD45+ cells 
have migrated into the cochlea. D) At fourteen days after injection, CD45+ cells continue to remain significantly 
high. E) By twenty-eight days after injection CD45+ cells are found in fewer numbers within the cochlea and are n
longer statistically significant from controls. 
o 
Lack of macrophage phagocytosis of OHC debris 
Whole mount preparations were labeled with the hair cell specific marker Myosin 
VIIa and common leukocyte receptor CD45 to determine if leukocytes phagocytose 
OHCs after ototoxic injury. A qualitative assessment was made of CD45+ cells within 
the area of the organ of Corti. It was predicted that leukocytes that had phagocytosed 
OHC debris would be labeled positively for both CD45 and Myosin VIIa. Although some 
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CD45+ cells were observed near the OHC region of the organ of Corti, no CD45+ cells 
were observed to be also marked with Myosin VIIa (Figure 7). In addition to whole 
mount preparations, we also examined mid-modiolar sections, in order to perceive a more 
three dimensional view of the cochlea. From these sections we observed CD45+ cells 
below the basilar 
membrane, but not within 
the organ of Corti (Figure 
8). 
DISCUSSION 
Hair cell loss progression 
 In the present study, 
large doses of kanamycin 
and furosemide were found 
to cause rapid OHC loss 
within the cochlea. Outer 
hair cells began to show signs of 
damage at two days after drug injections, but were not completely missing as was 
previously described by Taylor and colleagues (2008). Although Myosin VIIa was still 
expressed by OHCs in the basal region, some nuclei were not present. In between areas 
of complete OHC loss basally and OHC presence apically is a “transitional zone” of 
apoptotic and qualitatively intact OHCs. This is consistent with the “transitional zone” 
described by Taylor and colleagues (2008), where the ongoing apoptosis of OHCs begins 
in the higher frequency areas of the cochlea and proceeds through the cochlea to the 
Fig. 6. Average of CD45+ cells in each area of the cochlea 
by post injection day. 
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lower frequency areas. By PID five, 
OHCs were almost completely 
eliminated, except for a very few in 
the extreme apex of the cochlea. In 
contrast, IHC DAPI-stained nuclei 
and Moysin VIIa expression was 
observed even at PID twenty-eight. 
This observation differs from 
previous studies that found both IHC 
and OHC loss with this protocol in 
mice (Oesterle et al., 2008; Taylor et al., 2008). Different strains of mice are known to 
react differently to similar lesioning noise paradigms (Ohlemiller, Wright, & Heidbreder, 
2000), and the possibility remains that even a small difference in genetic make up could 
similarly affect IHC susceptibility in aminoglycoside and loop diuretic protocols.  
Fig. 7. Whole mount section depicting CD45+(green) 
macrophage cell (arrow) being recruited to the area where 
outer hair cells formerly were. 
 Several studies have indicated that aminoglycosides and loop diuretics both affect 
the SV, although loop diuretic affects on the SV are more commonly thought of (Forge & 
Schacht, 2000; Rybak, 1993; Wang & Steyger, 2009).  A study by Wang and colleagues 
described a fluorescently tagged aminoglycoside to preferentially reside within the SV 
that peaks three hours after IP injection and later diminishes. The authors concluded that 
this could indicate two mechanisms of aminoglycoside dispersion within the cochlea, 
either the SV works to sequester the drug from the endolymph in the scala media and/or 
that there is trans-strial trafficking of the drug from capillaries to marginal cells in the SV 
and then into the endolymph using the same paths as potassium ions into the hair cells. 
19 
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Regardless of the mechanisms, 
the result of aminoglycosides 
and loop diuretics targeting 
similar structures within the 
cochlea has been shown to 
provide a good method for 
non-invasive damage to the 
cochlea quickly. As kanamycin 
and furosemide act 
synergistically to damage the 
cochlea, it is possible that different concentrations could be used to reduce their effects. 
With the current kanamycin and furosemide dosages, cochlear lesioning happens too 
quickly to create a detailed timeline of events. 
Fig. 8. Section of cochlea stained with phalloidin (red) and 
CD45+ cells (green). CD45+ cells are below the organ of 
Corti (arrow) where the outer hair cells formerly were. 
Macrophage recruitment in response to cochlear injury 
 Resident macrophage populations and recruitment of macrophages after noise 
injury have been previously described (Hirose et al., 2005; Okana et al., 2008; Tan et al., 
2008; Sato et al., 2008). In our work CD45+ cell migration pattern is similar to that 
observed in previous studies that observed macrophage migration after acoustic trauma. 
Hirose and colleagues (2005) described macrophage recruitment starting at three days 
and remaining until approximately fourteen days after noise exposure. Our results are 
among the first findings using ototoxic drugs and observing macrophage recruitment.  
Our findings indicate that macrophages migrate into all areas of the cochlea with severe 
ototoxic damage caused by kanamycin and furosemide and remain elevated up to 
20 
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fourteen days after injection. It is not clear the exact mechanisms the macrophages play 
once recruited to the cochlea. It is not known if macrophages play a purely beneficial role 
in the cochlea after cochlear lesion. It is possible that inflammatory cells may cause more 
damage to the cochlea with their presence or function. Their cumulative presence within 
the lateral wall could hinder kanamycin diffusion from the cochlea, thus causing a 
prolonged exposure of OHCs to kanamycin, though this hypothesis has yet to be 
explored.  
It is not completely clear how macrophages within the cochlea are present in such 
large number after injury. A possibility exists that macrophages are recruited to the 
cochlea and simply accumulate for a period of time. There could also be a large 
recruitment of macrophages after injury, with macrophage migration out from the cochlea 
being held at a constant rate. A study by Sato (2008) and his colleagues demonstrated that 
there was turnover of macrophages within the cochlea, and that these macrophages were 
bone marrow derived from more distant parts of the body. The rate of macrophage 
turnover in injured versus non-injured cochleae has yet to be described. 
The fate of OHCs after ototoxic damage 
 There are several theories regarding the fate of damaged OHCs and their 
clearance from the organ of Corti. In our findings no OHC debris was observed in the 
organ of Corti. It is possible the OHCs are extruded into the scala media after apoptosis, 
making it difficult to impossible for other cells to phagocytose their debris. Conversely, a 
study by Abrashkin (2006) and colleagues found that OHC prestin accumulated in the 
supporting cells within the organ of Corti after ototoxic and acoustic injury. They 
concluded that supporting cells might take on a phagocytic role within the organ of Corti 
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after injury. It could be theorized that supporting cells do this in evolutionary response to 
the macrophages’ difficulty in reaching the organ of Corti. A different possibility may be 
that phagocytosis by macrophages of OHC debris may be a rapid event that was not 
observed in the intervals in this study.   
  Much insight has yet to be gained into the exact effects of the synergistic role 
kanamycin and furosemide damage and subsequent macrophage recruitment within the 
mouse cochlea. This rapid lesion protocol holds promise for future studies as a means of 
studying cochlear injury, subsequent observation of cochlear repair, and the potential of 
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